» Articles » PMID: 34076790

Circulating MiRNA 27a and MiRNA150-5p; a Noninvasive Approach to Endometrial Carcinoma

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2021 Jun 2
PMID 34076790
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The search for novel non-invasive biomarkers such as epigenetic molecular markers is new hope for common and burdensome cancers. We aim to assess serum expression of miRNA 27a and miRNA150-5p in endometrial cancer patients. Serum was drawn for 36 un-intervened endometrial cancer patients scheduled for hysterectomy and 35 controls. miRNA 27a and miRNA150-5p were measured by real time reverse transcription polymerase chain reaction. Significant overexpression of both miRNA in patients (p < 0.001). At cutoffs 0.2872 & > 1.02, miRNA 27a showed 100% sensitivity, specificity, positive and negative predictive values. miRNA150-5p showed 88.89% sensitivity, 100% specificity, 100% positive and 78.9% negative predictive values. Areas under curve were 1.0 for miRNA 27a, 0.982 for miRNA 150 performing much better than Ca125. miRNA 27a was significantly associated with type I endometroid endometrial cancer. Conclusion: miRNA 27a and miRNA-150-5P can be suggested as promising biomarkers of endometrial cancer possibly part of a miRNA panel for management.

Citing Articles

EXPRESSION LEVELS OF FOXO-1, P27KIP1, MIR-27, MIR-186 AND AKT1/AKT-P PROTEINS IN WOMEN WITH ENDOMETRIAL CANCER AND HYPERPLASIA: IMPLICATIONS FOR THE HUMAN REPRODUCTIVE SYSTEM.

Ghaderi P, Fallah S, Khaledi H, Tehranian A, Rahmati F, Sheikhhasani S Acta Endocrinol (Buchar). 2023; 19(1):1-9.

PMID: 37601705 PMC: 10439323. DOI: 10.4183/aeb.2023.1.


The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer.

Bogaczyk A, Zawlik I, Zuzak T, Kluz M, Potocka N, Kluz T Int J Mol Sci. 2023; 24(14).

PMID: 37511248 PMC: 10380838. DOI: 10.3390/ijms241411489.


Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects.

Piergentili R, Gullo G, Basile G, Gulia C, Porrello A, Cucinella G Int J Mol Sci. 2023; 24(14).

PMID: 37511115 PMC: 10379073. DOI: 10.3390/ijms241411356.


The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions.

Thakur L, Thakur S Front Endocrinol (Lausanne). 2023; 14:1166948.

PMID: 37152960 PMC: 10161733. DOI: 10.3389/fendo.2023.1166948.


Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis.

Karkia R, Wali S, Payne A, Karteris E, Chatterjee J Cancers (Basel). 2022; 14(19).

PMID: 36230588 PMC: 9563808. DOI: 10.3390/cancers14194666.


References
1.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

2.
Smith R, Andrews K, Brooks D, Fedewa S, Manassaram-Baptiste D, Saslow D . Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018; 68(4):297-316. DOI: 10.3322/caac.21446. View

3.
Reddy K . MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015; 15:38. PMC: 4424445. DOI: 10.1186/s12935-015-0185-1. View

4.
Zhu H, Fan G . Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis. 2011; 1(2):138-149. PMC: 3207246. View

5.
Lund E, Dahlberg J . Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb Symp Quant Biol. 2007; 71:59-66. DOI: 10.1101/sqb.2006.71.050. View